Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neurophysiological studies were performed on 22 randomly selected patients with
systemic lupus erythematosus
in order to determine whether this form of assessment might be of value in the diagnosis and management of neurological
lupus
. Sixteen patients described neurological
lupus
. In eight, neurological symptoms were present at the time of neurophysiological testing. All eight had neurophysiological abnormalities. In six the abnormality was of central origin manifesting as a disorder of either visual evoked response (VER) or brain-stem auditory evoked response (BAER). In the remaining two, an isolated disorder of peripheral nerve conduction (PNC) was present. In the eight patients with previous neurological symptoms five (63%) had neurophysiological abnormalities, but a central disorder was observed in only one and abnormal PNC was present in all. Of the six patients with no neurological symptoms, three (50%) had central neurophysiological disorders. No correlation between individual neurophysiological disorders and specific neurological symptoms was observed. However, all four patients with active vasculitis and all seven with
lymphopenia
had a neurophysiological disorder. If these observations are extended and confirmed, neurophysiological studies may provide a useful test to the clinician in the evaluation and management of neurological
lupus
.
...
PMID:Clinical neurophysiology in the assessment of neurological symptoms in systemic lupus erythematosus. 361 87
Systemic lupus erythematosus
(
SLE
) was diagnosed in 31 black Zimbabweans over a six year period. Renal involvement (71%) was more common and photosensitivity (16%) and serositis (23%) less common than in the United States.
Lymphopenia
(48%) was the commonest haematological abnormality. Unusual complications included subarachnoid haemorrhage, cardiac rhythm disturbance, portal and superior mesenteric vein thrombosis, and a non-Hodgkin lymphoma. Tuberculosis was a common differential diagnosis that was difficult to exclude. Nine patients (29%) died within one year of diagnosis.
SLE
is being recognised more commonly in Zimbabwe.
...
PMID:Systemic lupus erythematosus in Zimbabwe. 374 Sep 93
Four patients presented with the nephrotic syndrome. The histological appearances on renal biopsy were in three characteristic and in one suggestive of lupus nephritis. These patients did not initially have other clinical features of
SLE
, but three had a positive ANA and one a raised DNA titre. Remission occurred in two patients, in one spontaneously and in another following corticosteroid therapy, but two developed renal failure. During follow-up all developed elevated DNA binding levels and arthralgia or
lymphopenia
. The ARA classification criteria for
lupus
were only fulfilled at this late stage.
...
PMID:Lupus-like nephritis heralding the definitive manifestation of systemic lupus erythematosus. 387 72
Two out of 25 monoclonal anti-DNA autoantibodies that were produced by human-human hybridoma were found to have lymphocytotoxic activity. The antibodies reacted with normal B and T lymphocytes at cold (4 degrees C) as well as at warm (37 degrees C) temperatures. The lymphocytotoxic activity of the monoclonal anti-DNA antibodies could be inhibited by prior incubation of the antibodies with either polynucleotides, e.g. poly(I), poly(dT) or anti-idiotypic antibodies, that had been raised against a dominant anti-DNA antibody. The cross-reactivity between nuclear material and lymphocyte membrane raises the question whether these apparently diverse materials have a shared epitope. The cross-reactivity between anti-DNA antibodies and lymphocyte membrane may account in part for the
lymphopenia
observed in
systemic lupus erythematosus
patients.
...
PMID:Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies. 405 10
Peripheral blood T lymphocyte subsets were measured by flow cytometry in 122 patients with leprosy, in 23 normal controls, and in 27 patients with
systemic lupus erythematosus
(
SLE
). Active lepromatous patients not in reaction showed a significant
lymphopenia
and a significant proportionate reduction in the number of OKT3-positive (pan T), OKT4-positive (helper/inducer), and OKT8-positive (suppressor/cytotoxic) cells, but no alteration in distribution as judged by percentage and no abnormality in the helper: suppressor ratio. Borderline lepromatous subjects not in reaction had a significant selective deficiency in the number of cells of the OKT4-positive subset, with a significant but secondary
lymphopenia
and OKT3-positive cytopenia, a pattern similar to that found in
SLE
patients. Patients undergoing reversal reactions had a selective deficiency in the OKT4-positive subset in both absolute numbers and as a percentage of total lymphocytes, and a secondary deficiency in the percentage of OKT3-positive cells. No abnormalities were demonstrated in patients with active erythema nodosum leprosum, lepromatous patients with long-term treatment, and untreated or treated borderline tuberculoid patients.
...
PMID:Peripheral blood T lymphocyte subsets in leprosy. 633 90
We report 5 patients with
systemic lupus erythematosus
(
SLE
) who presented with severe protein-caloric malnutrition that overshadowed the clinical picture of
SLE
. All 5 patients had severe anemia, extreme
lymphopenia
and hypoalbuminemia, but all 5 also had striking hypergammaglobulinemia with high titers of autoantibodies. These patients show that
SLE
may occur in subjects with endemic malnutrition and suggest that the production of autoantibodies in
SLE
patients overrules the requirements for the production of other proteins.
...
PMID:Protein-caloric malnutrition and systemic lupus erythematosus. 676 88
Twenty-two haematological parameters were measured in 30 patients with
systemic lupus erythematosus
(
SLE
) at 110 patient attendances. Using a 10,000 cells per sample automated differential counter, the major abnormalities demonstrated were:
lymphopenia
, monocytopenia, eosinophilopenia (each of which showed strong correlation with steroid therapy) and increased numbers of cells of high peroxidase activity. Despite the common lymphocytopenia elevation of large unstained cells was noted in 20% of patients. However, no patient with severe disease had a lymphocyte count above 1.9 X 10(9)/l or a haemoglobin above 11.7 g/dl.
...
PMID:Haematological aspects of systemic lupus erythematosus: a reappraisal using automated methods. 681 Jun 23
A survey of the Western literature of histiocytic medullary reticulosis (malignant histiocytosis) provided 104 case reports with sufficient data from which the presence or absence of an absolute
lymphopenia
could be ascertained. Of these, 46 (44%) were lymphopenic at presentation or within the subsequent 10 days. A survey of a series of publications containing detailed peripheral leucocyte counts recorded in patients with diseases that, like HMR, may present with, or develop, pancytopenia showed that the incidence of
lymphopenia
ranged from 14% (Hodgkin's: stages I & II) to 46% (acute myelofibrosis;
systemic lupus erythematosus
; angio-immunoblastic lymphadenopathy). It was concluded a that HMR should be added to the list of accepted causes of
lymphopenia
, b that
lymphopenia
, as an aid to the diagnosis of HMR, will be of limited value, c that when the peripheral leucocyte count of a patient is recorded in a case report, it should be accompanied by a full differential count.
...
PMID:Lymphopenia in histiocytic medullary reticulosis. 685 38
The use of T cell subtyping to distinguish rheumatoid arthritis (RA) from
systemic lupus erythematosus
(
SLE
) was evaluated. We determined the distribution of IgG Fe receptor T cells (TG), IgM Fc receptor T cells (TM), and T cells lacking Fc receptors (Tnull) in 17 patients with RA and 7 patients with
SLE
. All RA patients including 3 antinuclear antibody positive-rheumatoid factor negative cases had normal numbers and percentages of TG, TM, and Tnull, whereas all
SLE
patients had a relative and absolute deficiency of TG. This TG
lymphopenia
was a better discriminator for
SLE
(7 of 7
SLE
, 0 of 17 RA) than anti-DNA antibodies, hypocomplementemia, circulating immune complexes or total number of T cells.
...
PMID:The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus. 697 81
Fas antigen (CD95) is a membrane-associated molecule that mediates apoptotic cell death and may play a role in the induction and maintenance of T cell tolerance. To elucidate the involvement of Fas antigen in human autoimmune diseases, we analysed Fas antigen expression by peripheral T cells from patients with
SLE
and rheumatoid arthritis (RA), using three-colour flow cytometry. Both CD4+ and CD8+ T cells from
SLE
patients expressed Fas antigen in a higher density than did these cells from healthy donors and from RA patients. Enhancement of Fas antigen density was noted in Fas+CD45RO+ memory T cells from
SLE
patients. More remarkably, a significant expression of Fas antigen was observed in CD45RO- naive T cells from
SLE
patients. CD4+CD45RO- T cells from
SLE
patients co-expressed Fas antigen and early to intermediate activation antigens such as CD25 and CD71, and late activation antigen HLA-DR in only FashiCD4+ naive T cells. Such up-regulation of Fas antigen expression in
SLE
patients seems to be clinically meaningful, because mean fluorescence intensity (MFI) of Fas antigen on CD4+ T cell subsets inversely correlates with the absolute size of CD4+ T cell subsets in peripheral blood of
SLE
patients. These results suggest that T cells with increased Fas antigen expression may be highly susceptible to apoptotic cell death, in vivo. A putative mechanism for
lymphopenia
in
SLE
patients is discussed.
...
PMID:Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. 753 28
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>